Sample result
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
GLP-1, a diabetes hormone
Protein → Patent proteins · Automatic (Smith-Waterman)
Every list and the search record, one sheet each.
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Charts
Identity against coverage
5,000 hits by identity and query coverage. 5,000 with a date.
Show table
| Band | Has a date | All |
|---|---|---|
| 100% | 553 | 553 |
| 95 to 99.9% | 992 | 992 |
| 90 to 94.9% | 2,638 | 2,638 |
| 80 to 89.9% | 814 | 814 |
| 70 to 79.9% | 3 | 3 |
| Band | Has a date | All |
|---|---|---|
| 100% | 3,606 | 3,606 |
| 95 to 99.9% | 876 | 876 |
| 90 to 94.9% | 483 | 483 |
| 80 to 89.9% | 35 | 35 |
Hits by year
3,061 publications by year of first publication, 1990 to 2026.
Show table
| Year | Has a date | All |
|---|---|---|
| 1990 | 2 | 2 |
| 1992 | 2 | 2 |
| 1993 | 1 | 1 |
| 1994 | 1 | 1 |
| 1995 | 1 | 1 |
| 1996 | 3 | 3 |
| 1997 | 2 | 2 |
| 1998 | 2 | 2 |
| 1999 | 11 | 11 |
| 2000 | 13 | 13 |
| 2001 | 20 | 20 |
| 2002 | 37 | 37 |
| 2003 | 33 | 33 |
| 2004 | 37 | 37 |
| 2005 | 54 | 54 |
| 2006 | 62 | 62 |
| 2007 | 77 | 77 |
| 2008 | 81 | 81 |
| 2009 | 107 | 107 |
| 2010 | 101 | 101 |
| 2011 | 110 | 110 |
| 2012 | 121 | 121 |
| 2013 | 123 | 123 |
| 2014 | 135 | 135 |
| 2015 | 142 | 142 |
| 2016 | 144 | 144 |
| 2017 | 157 | 157 |
| 2018 | 149 | 149 |
| 2019 | 150 | 150 |
| 2020 | 156 | 156 |
| 2021 | 183 | 183 |
| 2022 | 161 | 161 |
| 2023 | 175 | 175 |
| 2024 | 181 | 181 |
| 2025 | 231 | 231 |
| 2026 | 96 | 96 |
Where hits align on the query
The top 20 hits on GLP-1, a query of 31 amino acids: 20 cover the whole query, none differs from it.
Show table
| Hit | Query from | Query to | Identity | Differs at | Gaps at | X at |
|---|---|---|---|---|---|---|
| AAA55132.1 | 1 | 31 | 100.0% | None | None | None |
| A31422.1 | 1 | 31 | 100.0% | None | None | None |
| AAB11984.1 | 1 | 31 | 100.0% | None | None | None |
| DI506186 | 1 | 31 | 100.0% | None | None | None |
| DI527435 | 1 | 31 | 100.0% | None | None | None |
| AAB11995.1 | 1 | 31 | 100.0% | None | None | None |
| AAE02614.1 | 1 | 31 | 100.0% | None | None | None |
| DI540976 | 1 | 31 | 100.0% | None | None | None |
| DI521338 | 1 | 31 | 100.0% | None | None | None |
| DI502216 | 1 | 31 | 100.0% | None | None | None |
| DJ789879 | 1 | 31 | 100.0% | None | None | None |
| DI520483 | 1 | 31 | 100.0% | None | None | None |
| AAE49428.1 | 1 | 31 | 100.0% | None | None | None |
| AAE49430.1 | 1 | 31 | 100.0% | None | None | None |
| AAE49429.1 | 1 | 31 | 100.0% | None | None | None |
| AAE49432.1 | 1 | 31 | 100.0% | None | None | None |
| DI501808 | 1 | 31 | 100.0% | None | None | None |
| AAY78103.1 | 1 | 31 | 100.0% | None | None | None |
| BD613525 | 1 | 31 | 100.0% | None | None | None |
| BD613528 | 1 | 31 | 100.0% | None | None | None |
Patents 3.1K
3,061 publications from 692 applicants, 83 with no applicant, match these filters.
Conjuchem, Inc. 23 publications, continued
-
US 6514500-A2003-02-04
Long lasting synthetic glucagon like peptide {GLP-!}
Conjuchem, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6593295-A2003-07-15
Long lasting insulinotropic peptides
Conjuchem, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2003527312-A2003-09-16
LONG LASTING INSULINOTROPIC PEPTIDES
ConjuChem Inc
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6821949-A2004-11-23
Long lasting synthetic glucagon-like peptide (GLP-1)
ConjuChem, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6849714-A2005-02-01
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
ConjuChem, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
-
US 6887470-A2005-05-03
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
Conjuchem, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
-
US 6887849-A2005-05-03
Long lasting synthetic glucagon-like peptide {GLP-1}
ConjuChem, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2005239736-A2005-09-08
Modified Secretin and Method of Synthesizing Thereof
Conjuchem Inc
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
-
JP 2005255689-A2005-09-22
LONG LASTING EXENDIN-4
ConjuChem Inc
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2005263807-A2005-09-29
Modified Peptides YY and Conjugates Thereof
Conjuchem Inc
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
-
EP 1591453-A12005-11-02
No title on record
ConjuChem Inc. (CA)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
-
EP 1598365-A12005-11-23
No title on record
ConjuChem Inc. (CA)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
-
JP 2006151986-A2006-06-15
LONG LASTING EXENDIN-4
ConjuChem Inc
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 8039432-B22011-10-18
Method of treatment of diabetes and/or obesity with reduced nausea side effect
Conjuchem, LLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 8080516-B22011-12-20
Long lasting synthetic exendin-4 peptide conjugates
Conjuchem, LLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 8084414-B22011-12-27
Methods involving long lasting synthetic exendin-4-peptide conjugates
Conjuchem, LLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 8093206-B22012-01-10
Methods involving long lasting synthetic exendin-4 peptide conjugates
Conjuchem, LLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0117568-A22001-03-15
Pulmonary delivery for bioconjugation
Conjuchem, Inc. (CA)
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
JP 2003508501-A2003-03-04
PULMONARY DELIVERY FOR BIOCONJUGATION
CONJUCHEM INC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 6706892-A2004-03-16
Pulmonary delivery for bioconjugation
Conjuchem, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Zealand Pharmaceuticals A/S (DK) 4 publications
-
WO 0104156-A12001-01-18
Peptides that lower blood glucose levels
Zealand Pharmaceuticals A/S (DK)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2007001987-A2007-01-11
PEPTIDES THAT LOWER BLOOD GLUCOSE LEVELS
ZEALAND PHARMACEUTICALS
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2002509082-A2002-03-26
Pharmacologically active peptide complex with reduced tendency against enzymatic hydrolysis
ZEALAND PHARMACEUTICALS AS
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 1076066-A12001-02-14
Peptides for lowering blood glucose levels
Zealand Pharmaceuticals A/S (DK)
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | |||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 30 identical, no gaps.
Bayer Corporation 2 publications
-
WO 0123420-A22001-04-05
Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use
Bayer Corporation (US)
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 7507714-A2009-03-24
Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
Bayer Corporation
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
TRANSKARYOTIC THERAPIES INC 2 publications
-
WO 0136643-A12001-05-25
Nucleic acid construct for optimized production of products
TRANSKARYOTIC THERAPIES, INC. (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2003514532-A2003-04-22
Nucleic acid construct for optimized production of products
TRANSKARYOTIC THERAPIES INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Scios Inc 4 publications
-
JP 2001158749-A2001-06-12
Sustained release of peptide
SCIOS INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2004099621-A2004-04-02
Prolonged Delivery of Peptides
Scios Inc
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6828303-A2004-12-07
Prolonged delivery of peptides
Scios, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2006213727-A2006-08-17
Prolonged Delivery of Peptides
SCIOS INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Eli Lilly and Company 205 publications
-
WO 0155213-A22001-08-02
Process for solubilizing glucagon-like peptide 1 compounds
ELI LILLY AND COMPANY (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0198331-A22001-12-27
Glucagon-like peptide-1 analogs
ELI LILLY AND COMPANY (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2002507188-A2002-03-05
Use of glucagon-like peptide-1 (GLP-1) or analogs to abolish catabolic changes after surgery
ELI LILLY & CO
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2002508332-A2002-03-19
Glucagon-like peptide-1 crystals
ELI LILLY AND CO
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0246227-A22002-06-13
Glp-1 fusion proteins
ELI LILLY AND COMPANY (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0247715-A22002-06-20
Compositions of peptide crystals
ELI LILLY AND COMPANY (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0248183-A22002-06-20
Compositions of peptide crystals
ELI LILLY AND COMPANY (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0248192-A22002-06-20
Amidated glucagon-like peptide-1
ELI LILLY AND COMPANY (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2002526454-A2002-08-20
Use of GLP-1 or analogs in treatment of stroke
ELI LILLY AND CO
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6555521-A2003-04-29
Glucagon-like peptide-1 crystals
Eli Lilly and Company
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 1306092-A22003-05-02
Use of glp-1 and analogs administered peripherally, in regulation of obesity
Eli Lilly & Company (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6583111-A2003-06-24
Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesity
Eli Lilly and Company
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2003523366-A2003-08-05
Process for Solubilizing Glucagon-Like Peptide 1 Compounds
Eli Lilly and Company
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2004501162-A2004-01-15
GLUCAGON-LIKE PEPTIDE-1 ANALOGS
Eli Lilly and Company
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 1396499-A22004-03-10
Process for solubilizing glucagon-like peptide 1 (GLP-1) compounds
ELI LILLY AND COMPANY (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6747006-A2004-06-08
Use of GLP-1 or analogs in treatment of myocardial infarction
Eli Lilly and Company
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2005000892-A22005-01-06
Glp-1 analog fusion plroteins
Eli Lilly and Company (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 1566180-A22005-08-24
No title on record
Eli Lilly & Company (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.